LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(92 sites)

United States

Tenax Investigational Site, Alexander City, Alabama

Tenax Investigational Site, Tamarac, Florida

Tenax Investigational Site, Mount Prospect, Illinois

Tenax Investigational Site, Peoria, Illinois

Tenax Investigational Site, New Orleans, Louisiana